Opioid Analgesic REMS Training offers a multimodal, FDA Blueprint–aligned learning experience w/ live interactive webinars, patient simulations, and on-demand modules to help healthcare professionals deliver safe, compassionate pain management.

The goal of this activity is to improve the knowledge and competence of learners in supporting prompt recognition, diagnosis, and management of patients with systemic mastocytosis.

The goal of this activity is to improve the knowledge and competence of learners in diagnosing and managing systemic mastocytosis so that patients will experience improvements in symptoms and quality of life and reduced disease progression.

This REMS-compliant dinner program is designed to enhance clinician confidence and competence in the safe and effective management of pain.

The PREPARE Summit program is an interactive, case-based educational series designed to help clinicians identify, evaluate, and manage early cognitive decline in primary care settings, led by experts in neurology, geriatrics, and primary care.

Join us for a complimentary dinner and CME as our experts discuss the latest efficacy and safety data from clinical trials of newly approved and emerging therapies and new therapeutic combinations for small cell lung cancer (SCLC).

Hear expert guidance on how to inform decisions about advancing therapy and to recognize all patients who would benefit from approved biologic therapies targeting IL-13 based on the pathophysiology of Atopic Dermatitis.

Join us for a complimentary dinner and CME as our experts discuss the latest efficacy and safety data from clinical trials of newly approved and emerging therapies and new therapeutic combinations for small cell lung cancer (SCLC).

Join us for a complimentary dinner and CME as our experts discuss the latest efficacy and safety data from clinical trials of newly approved and emerging therapies and new therapeutic combinations for small cell lung cancer (SCLC).

Join us for a complimentary dinner and CME as our experts discuss the latest efficacy and safety data from clinical trials of newly approved and emerging therapies and new therapeutic combinations for small cell lung cancer (SCLC).